本页面由Tiger Trade Technology Pte. Ltd.提供服务

Rhythm Pharmaceuticals Inc.

86.29
-1.8300-2.08%
盘后86.290.00000.00%16:20 EDT
成交量:54.65万
成交额:4,750.73万
市值:58.92亿
市盈率:-27.78
高:88.64
开:85.81
低:85.74
收:88.12
52周最高:122.20
52周最低:45.91
股本:6,828.50万
流通股本:5,547.75万
量比:0.42
换手率:0.98%
股息:- -
股息率:- -
每股收益(TTM):-3.1057
每股收益(LYR):-3.1100
净资产收益率:-90.45%
总资产收益率:-27.51%
市净率:42.37
市盈率(LYR):-27.75

数据加载中...

2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/04

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/19

重要事件披露

Form 8-K - Current report
2023/12/06

重要事件披露

Form 8-K - Current report
2023/12/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities